# ChronicleBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chroniclebio

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.chroniclebio.com
- Total disclosed funding: $15M
- Latest round: Seed (Aug 3, 2026)
- Investors on record: 2

## About

Founded in 2025 and based in California, US, ChronicleBio operates as a biotechnology company that collects patient data and biological samples and applies data analysis tools to support research on chronic diseases and therapeutic development.

## Funding rounds

- Seed, Aug 3, 2026, $15M — Tarsadia Investments, Electric Capital

## Investors

- Tarsadia Investments — Seed
- Electric Capital (https://capitalatlas.ai/funds/electric-capital) — Seed